NCT03692325
- Conditions
- Head and Neck Neoplasms, Leukoplakia, Leukoplakia, Oral, +8 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Leukoplakia, Oral. Study availability and eligibility vary by location and protocol.
NCT03692325
NCT06469892
NCT05730855
NCT00099021
NCT03239834
NCT04712929
NCT00299195
NCT03682562
NCT04153266
NCT04267419